| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8e2e8dd0b35cc972b083d5345ad1bd28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B63H20-00 |
| filingDate |
2006-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a828b097d6f3d60f7d7ea53c92a1462 |
| publicationDate |
2006-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006124556-A2 |
| titleOfInvention |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| abstract |
Pharmaceutical formulations suitable for inhalation comprise at least one pharmaceutically active medicament and lactose anhydrate. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2400950-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729647-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116721-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105228599-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10022323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014155134-A1 |
| priorityDate |
2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |